Virtu Financial’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42K Buy
12,863
+3,466
+37% +$9.53K ﹤0.01% 1244
2026
Q1
$31K Buy
+9,397
New +$46.6K ﹤0.01% 1350
2025
Q2
Sell
-272
Closed -$12K 1957
2025
Q1
$12K Buy
+272
New +$17.4K ﹤0.01% 1163
2024
Q1
Sell
-231
Closed -$59K 1974
2023
Q4
$59K Buy
+231
New +$63.3K ﹤0.01% 1146
2023
Q3
Sell
-138
Closed -$6K 1785
2023
Q2
$6K Buy
+138
New +$10.6K ﹤0.01% 1389
2022
Q1
Sell
-279
Closed -$163K 1940
2021
Q4
$163K Buy
+279
New +$203K 0.02% 919
2021
Q3
Sell
-850
Closed -$338K 1883
2021
Q2
$338K Buy
+850
New +$277K 0.03% 660
2021
Q1
Sell
-223
Closed -$53K 1948
2020
Q4
$53K Buy
+223
New +$56.3K 0.01% 1218

Other funds holding LNAI

Virtu Financial's LNAI Position: Q2 2026 in Review

Virtu Financial increased its Lunai Bioworks (LNAI) stake by 37% in Q2 2026, buying an estimated $9.53K and bringing the position to 12,863 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Virtu Financial first reported a position in LNAI in Q4 2020 and has held it in 8 quarters since. The position peaked at $338K in Q2 2021. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Virtu Financial held 12,863 shares of Lunai Bioworks worth $42K as of Q2 2026.
  • Virtu Financial bought 3,466 Lunai Bioworks shares in Q2 2026, an estimated $9.53K.
  • Lunai Bioworks made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1244 holding.
  • Virtu Financial first reported a position in Lunai Bioworks in Q4 2020 and has held it in 8 quarters since.
  • Virtu Financial's Lunai Bioworks position peaked at $338K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.